Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Teratoma 1Choriocarcinoma 1Carcinoma, Embryonal 1

Interventions

Etoposide 8Cisplatin 6Bleomycin 6Filgrastim 4Peripheral Blood Stem Cell Transplantation 3Ifosfamide 3Carboplatin 3etoposide phosphate 2Thiotepa 2Specimen Handling 2Radiotherapy 2Mesna 2Magnetic Resonance Spectroscopy 2Granulocyte Colony-Stimulating Factor 2sodium thiosulfate 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1liposomal amphotericin B 1Taxes 1Surgical Procedures, Operative 1Standard of Care 1Second-Look Surgery 1Restraint, Physical 1Respiratory Physiological Phenomena 1Reoperation 1Radiation 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Polymerase Chain Reaction 1Platinum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Teratoma × Second-Look Surgery × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡